Monashee Investment Management’s Oncobiologics, Inc. Series B Warrant ONSIZ Stock Holding History

Monashee Investment Management’s Portfolio ONSIZ Stock Details ONSIZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-25,000	Closed	-$1K	–	248
2018 Q1	$1K	Buy	+25,000	New	+$983	﹤0.01%	141
2017 Q4	–	Hold	0	–	–	–	134
2017 Q3	–	Sell	-25,000	Closed	-$1.65K	–	81
2017 Q2	$2K	Buy	+25,000	New	+$4.55K	﹤0.01%	84
2017 Q1	–	Sell	-25,000	Closed	-$10.8K	–	81
2016 Q4	$20K	Buy	+25,000	New	+$19.3K	0.01%	83
2016 Q3	–	Hold	0	–	–	–	85
2016 Q2	–	Hold	0	–	–	–	57

Monashee Investment Management's ONSIZ Position: Q2 2018 in Review

Monashee Investment Management sold out of Oncobiologics, Inc. Series B Warrant (ONSIZ) in Q2 2018, closing a stake of 25,000 shares — an estimated $1K sold.

Monashee Investment Management first reported a position in ONSIZ in Q4 2016 and held it in 3 quarters. The position peaked at $20K in Q4 2016. 0 funds tracked by Wall St. Rank hold ONSIZ as of Q2 2018.

Monashee Investment Management reported no remaining Oncobiologics, Inc. Series B Warrant position as of Q2 2018 after selling out during the quarter.
Monashee Investment Management sold 25,000 Oncobiologics, Inc. Series B Warrant shares in Q2 2018, an estimated $1K.
Monashee Investment Management first reported a position in Oncobiologics, Inc. Series B Warrant in Q4 2016 and held it in 3 quarters.
Monashee Investment Management's Oncobiologics, Inc. Series B Warrant position peaked at $20K in Q4 2016.
0 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series B Warrant as of Q2 2018.

Based on Monashee Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.